PDL BioPharma Shares Outstanding 2006-2020 | PDLI

PDL BioPharma shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
PDL BioPharma Annual Shares Outstanding
(Millions of Shares)
2019 119
2018 146
2017 156
2016 164
2015 164
2014 173
2013 159
2012 146
2011 177
2010 179
2009 184
2008 168
2007 141
2006 140
2005 104
PDL BioPharma Quarterly Shares Outstanding
(Millions of Shares)
2020-06-30 116
2020-03-31 123
2019-12-31 119
2019-09-30 113
2019-06-30 118
2019-03-31 129
2018-12-31 146
2018-09-30 144
2018-06-30 147
2018-03-31 153
2017-12-31 156
2017-09-30 152
2017-06-30 156
2017-03-31 164
2016-12-31 164
2016-09-30 164
2016-06-30 164
2016-03-31 164
2015-12-31 164
2015-09-30 164
2015-06-30 165
2015-03-31 170
2014-12-31 173
2014-09-30 167
2014-06-30 177
2014-03-31 165
2013-12-31 159
2013-09-30 155
2013-06-30 152
2013-03-31 149
2012-12-31 146
2012-09-30 150
2012-06-30 142
2012-03-31 140
2011-12-31 177
2011-09-30 167
2011-06-30 186
2011-03-31 190
2010-12-31 179
2010-09-30 172
2010-06-30 173
2010-03-31 184
2009-12-31 184
2009-09-30 169
2009-06-30 170
2009-03-31 173
2008-12-31 168
2008-09-30 153
2008-06-30 152
2008-03-31 141
2007-12-31 117
2007-09-30 117
2007-06-30 120
2007-03-31 118
2006-12-31 114
2006-09-30 114
2006-06-30 114
2006-03-31 112
2005-12-31 112
2005-09-30 105
2005-06-30 104
2005-03-31 97
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.282B $0.055B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $147.580B 15.43
Bristol Myers Squibb (BMY) United States $146.079B 10.41
CSL (CSLLY) Australia $96.828B 0.00
Gilead Sciences (GILD) United States $83.911B 11.16
Vertex Pharmaceuticals (VRTX) United States $61.782B 28.73
Illumina (ILMN) United States $59.313B 81.58
Regeneron Pharmaceuticals (REGN) United States $57.384B 20.36
Moderna (MRNA) United States $51.846B 0.00
Biogen (BIIB) United States $41.462B 7.37
Alexion Pharmaceuticals (ALXN) United States $34.956B 13.93
BeiGene (BGNE) Cayman Islands $34.151B 0.00
Seagen (SGEN) United States $33.059B 87.02
Genmab (GMAB) Denmark $28.224B 33.38
Genmab (GNMSF) Denmark $26.832B 6.18
BioNTech SE (BNTX) Germany $24.536B 0.00
Exact Sciences (EXAS) United States $22.564B 0.00
Incyte (INCY) United States $21.438B 0.00
Alnylam Pharmaceuticals (ALNY) United States $20.027B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.449B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.603B 66.75
Horizon Therapeutics Public (HZNP) Ireland $17.156B 24.52
Guardant Health (GH) United States $15.988B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.973B 106.01
ARGENX SE-ADR (ARGX) Netherlands $14.722B 0.00
Bio-Techne Corp (TECH) United States $13.768B 88.05
CRISPR Therapeutics AG (CRSP) Switzerland $13.422B 0.00
QIAGEN (QGEN) Netherlands $12.374B 27.86
Repligen (RGEN) United States $11.540B 163.67
Mirati Therapeutics (MRTX) United States $10.783B 0.00
Denali Therapeutics (DNLI) United States $9.489B 0.00
Twist Bioscience (TWST) United States $9.268B 0.00
Adaptive Biotechnologies (ADPT) United States $9.265B 0.00
Ascendis Pharma (ASND) Denmark $8.582B 0.00
Ultragenyx Pharmaceutical (RARE) United States $8.575B 0.00
Fate Therapeutics (FATE) United States $8.479B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.399B 0.00
Novavax (NVAX) United States $8.084B 0.00
Sarepta Therapeutics (SRPT) United States $7.752B 0.00
Acceleron Pharma (XLRN) United States $7.508B 0.00
Galapagos (GLPG) Belgium $7.273B 0.00
Exelixis (EXEL) United States $6.869B 46.13
Halozyme Therapeutics (HALO) United States $6.692B 309.38
NeoGenomics (NEO) United States $6.221B 1867.67
SWEDISH ORP BIO (BIOVF) Sweden $6.009B 17.57
Beam Therapeutics (BEAM) United States $5.768B 0.00
Certara (CERT) United States $5.711B 0.00
Emergent Biosolutions (EBS) United States $5.677B 18.63
Blueprint Medicines (BPMC) United States $5.649B 18.70
Amicus Therapeutics (FOLD) United States $5.496B 0.00
Vir Biotechnology (VIR) United States $5.163B 0.00
Eidos Therapeutics (EIDX) United States $4.991B 0.00
China Biologic Products (CBPO) China $4.655B 30.17
Arena Pharmaceuticals (ARNA) United States $4.518B 0.00
Intellia Therapeutics (NTLA) United States $4.393B 0.00
Insmed (INSM) United States $4.278B 0.00
Editas Medicine (EDIT) United States $4.122B 0.00
Arvinas (ARVN) United States $4.071B 0.00
Reata Pharmaceuticals (RETA) United States $3.868B 0.00
MorphoSys AG (MOR) Germany $3.867B 139.95
Legend Biotech (LEGN) United States $3.535B 0.00
Alkermes (ALKS) Ireland $3.532B 34.67
I-Mab (IMAB) China $3.152B 0.00
Bluebird Bio (BLUE) United States $3.096B 0.00
Global Blood Therapeutics (GBT) United States $2.945B 0.00
Intra-Cellular Therapies (ITCI) United States $2.671B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.662B 0.00
Amarin (AMRN) Ireland $2.561B 0.00
Sorrento Therapeutics (SRNE) United States $2.535B 0.00
Arcus Biosciences (RCUS) United States $2.494B 0.00
Zymeworks (ZYME) Canada $2.390B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.298B 0.00
Ligand Pharmaceuticals (LGND) United States $2.293B 59.42
Seres Therapeutics (MCRB) United States $2.195B 0.00
Sangamo Therapeutics (SGMO) United States $2.115B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.057B 17.03
Myriad Genetics (MYGN) United States $2.003B 0.00
NGM Biopharmaceuticals (NGM) United States $1.974B 0.00
PHARMA MAR SA (PHMMF) Spain $1.959B 0.00
Scholar Rock Holding (SRRK) United States $1.933B 0.00
Viela Bio (VIE) United States $1.912B 0.00
Revance Therapeutics (RVNC) United States $1.903B 0.00
Genetron Holdings (GTH) China $1.875B 0.00
NantKwest (NK) United States $1.873B 0.00
Vericel (VCEL) United States $1.873B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.849B 0.00
UniQure (QURE) Netherlands $1.747B 0.00
Precigen (PGEN) United States $1.708B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.658B 0.00
REGENXBIO (RGNX) United States $1.619B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.604B 0.00
Castle Biosciences (CSTL) United States $1.596B 0.00
Heska (HSKA) United States $1.564B 0.00
Codexis (CDXS) United States $1.539B 0.00
Inovio Pharmaceuticals (INO) United States $1.525B 0.00
Bionano Genomics (BNGO) United States $1.501B 0.00
Zealand Pharma (ZEAL) Denmark $1.480B 0.00
Cytokineticsorporated (CYTK) United States $1.441B 0.00
Travere Therapeutics (TVTX) United States $1.413B 0.00
Mersana Therapeutics (MRSN) United States $1.358B 0.00
Zealand Pharma (ZLDPF) Denmark $1.343B 0.00
Cellectis S.A (CLLS) France $1.329B 0.00
Coherus BioSciences (CHRS) United States $1.321B 8.73
Alector (ALEC) United States $1.315B 0.00
Frequency Therapeutics (FREQ) United States $1.307B 0.00
Adverum Biotechnologies (ADVM) United States $1.305B 0.00
Antibe Therapeutics (ATBPF) Canada $1.227B 0.00
Northwest Biotherapeutics (NWBO) United States $1.195B 0.00
Epizyme (EPZM) United States $1.163B 0.00
Athenex (ATNX) United States $1.156B 0.00
Mesoblast (MESO) Australia $1.087B 0.00
Sutro Biopharma (STRO) United States $1.063B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.031B 0.00
Gritstone Oncology (GRTS) United States $1.024B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.992B 0.00
MiMedx (MDXG) United States $0.986B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.972B 0.00
Morphic Holding (MORF) United States $0.971B 0.00
Cara Therapeutics (CARA) United States $0.954B 0.00
Pliant Therapeutics (PLRX) United States $0.940B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 24.17
Merus (MRUS) Netherlands $0.860B 0.00
Compugen (CGEN) Israel $0.858B 0.00
Protagonist Therapeutics (PTGX) United States $0.855B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.827B 0.00
Kadmon Holdings (KDMN) United States $0.827B 0.00
MannKind (MNKD) United States $0.823B 0.00
Avid Bioservices (CDMO) United States $0.808B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.778B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.777B 39.44
VBI Vaccines (VBIV) United States $0.746B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.729B 0.00
Celldex Therapeutics (CLDX) United States $0.704B 0.00
AnaptysBio (ANAB) United States $0.698B 0.00
Precision BioSciences (DTIL) United States $0.697B 0.00
Syros Pharmaceuticals (SYRS) United States $0.685B 0.00
AquaBounty Technologies (AQB) United States $0.670B 0.00
Albireo Pharma (ALBO) United States $0.669B 0.00
Agenus (AGEN) United States $0.654B 0.00
DBV Technologies S.A (DBVT) France $0.651B 0.00
Curis (CRIS) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.639B 0.00
MeiraGTx Holdings (MGTX) United States $0.600B 0.00
Clovis Oncology (CLVS) United States $0.590B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.579B 0.00
Affimed (AFMD) Germany $0.576B 0.00
Dynavax Technologies (DVAX) United States $0.575B 0.00
Five Prime Therapeutics (FPRX) United States $0.563B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.559B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.559B 0.00
Anika Therapeutics (ANIK) United States $0.554B 74.92
Prothena (PRTA) Ireland $0.543B 0.00
Geron (GERN) United States $0.537B 0.00
Pandion Therapeutics (PAND) United States $0.535B 0.00
Spero Therapeutics (SPRO) United States $0.511B 0.00
FORTE BIOSCIENC (FBRX) United States $0.500B 0.00
WAVE Life Sciences (WVE) Singapore $0.486B 0.00
Amryt Pharma (AMYT) United Kingdom $0.478B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.475B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.474B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.458B 0.00
AC Immune SA (ACIU) Switzerland $0.454B 0.00
Starpharma Holdings (SPHRY) Australia $0.454B 0.00
Puma Biotechnology (PBYI) United States $0.443B 0.00
UROGEN PHARMA (URGN) United States $0.439B 0.00
XOMA (XOMA) United States $0.433B 0.00
Cue Biopharma (CUE) United States $0.426B 0.00
BioDelivery Sciences (BDSI) United States $0.419B 19.71
Kala Pharmaceuticals (KALA) United States $0.417B 0.00
ANI Pharmaceuticals (ANIP) United States $0.397B 10.09
Cardiff Oncology (CRDF) United States $0.385B 0.00
Athersys (ATHX) United States $0.384B 0.00
NextCure (NXTC) United States $0.375B 0.00
Verastem (VSTM) United States $0.374B 0.00
Selecta Biosciences (SELB) United States $0.372B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.366B 0.00
Cellular Biomedicine (CBMG) United States $0.355B 0.00
Innate Pharma S.A (IPHA) France $0.355B 0.00
Trevena (TRVN) United States $0.347B 0.00
Arbutus Biopharma (ABUS) United States $0.344B 0.00
AMMO (POWW) United States $0.342B 0.00
Voyager Therapeutics (VYGR) United States $0.339B 8.69
Fortress Biotech (FBIO) United States $0.332B 0.00
Kamada (KMDA) Israel $0.309B 14.48
CytomX Therapeutics (CTMX) United States $0.307B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.304B 0.00
ChromaDex (CDXC) United States $0.303B 0.00
Bellus Health (BLU) Canada $0.301B 0.00
HOOKIPA Pharma (HOOK) United States $0.279B 0.00
OSMOTICA PHARM (OSMT) United States $0.279B 0.00
Cerecor (CERC) United States $0.262B 0.00
Aptinyx (APTX) United States $0.253B 0.00
Checkpoint Therapeutics (CKPT) United States $0.246B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.242B 0.00
ADMA Biologics Inc (ADMA) United States $0.230B 0.00
Eton Pharmaceuticals (ETON) United States $0.224B 0.00
Cogent Biosciences (COGT) United States $0.222B 0.00
Theratechnologies (THTX) Canada $0.215B 0.00
TELA Bio (TELA) United States $0.214B 0.00
Idera Pharmaceuticals (IDRA) United States $0.210B 0.00
Abeona Therapeutics (ABEO) United States $0.209B 0.00
GENFIT S.A (GNFT) France $0.204B 0.00
Exicure (XCUR) United States $0.204B 0.00
Strongbridge Biopharma (SBBP) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Kindred Biosciences (KIN) United States $0.195B 0.00
Pluristem Therapeutics (PSTI) Israel $0.194B 0.00
Biofrontera AG (BFRA) Germany $0.191B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.185B 0.00
Clearside Biomedical (CLSD) United States $0.183B 0.00
Nicox SA (NICXF) France $0.182B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.180B 0.00
Oncobiologics (OTLK) United States $0.169B 0.00
DiaMedica Therapeutics (DMAC) United States $0.167B 0.00
VTv Therapeutics (VTVT) United States $0.163B 0.00
Dyadic (DYAI) United States $0.161B 0.00
Lumos Pharma (LUMO) United States $0.159B 0.00
Evogene (EVGN) Israel $0.158B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.155B 0.00
Orgenesis (ORGS) United States $0.154B 318.00
Prometic Life Sciences (LMNL) Canada $0.152B 0.00
Catalyst Biosciences (CBIO) United States $0.152B 0.00
Aptevo Therapeutics (APVO) United States $0.147B 0.00
Enzo Biochem (ENZ) United States $0.147B 0.00
TRACON Pharmaceuticals (TCON) United States $0.145B 0.00
Cocrystal Pharma (COCP) United States $0.145B 0.00
Synlogic (SYBX) United States $0.142B 0.00
Seelos Therapeutics (SEEL) United States $0.138B 0.00
Ecology Coatings (ABVC) United States $0.129B 0.00
Vascular Biogenics (VBLT) Israel $0.129B 0.00
PHASEBIO PHARMA (PHAS) United States $0.127B 0.00
Liquidia Technologies (LQDA) United States $0.127B 0.00
Prima BioMed (IMMP) Australia $0.125B 0.00
Applied Genetic Technologies (AGTC) United States $0.123B 0.00
AIT Therapeutics (XAIR) United States $0.122B 0.00
Celyad SA (CYAD) Belgium $0.116B 0.00
Cyclerion Therapeutics (CYCN) United States $0.114B 0.00
Cidara Therapeutics (CDTX) United States $0.110B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.110B 0.00
Aytu Bioscience (AYTU) United States $0.105B 0.00
Organovo Holdings (ONVO) United States $0.102B 0.00
Novogen (KZIA) Australia $0.099B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Stealth BioTherapeutics (MITO) United States $0.093B 44.75
Windtree Therapeutics (WINT) United States $0.092B 0.00
Adocia (ADOCY) France $0.091B 0.00
CytRx (CYTR) United States $0.089B 0.00
CollPlant Holdings (CLGN) Israel $0.083B 0.00
Genetic Technologies (GENE) Australia $0.075B 0.00
Purple Biotech (PPBT) Israel $0.072B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
AnPac Bio-Medical Science (ANPC) China $0.066B 0.00
Emmaus Life Sciences (EMMA) United States $0.065B 0.00
Edesa Biotech (EDSA) Canada $0.061B 0.00
Acorda Therapeutics (ACOR) United States $0.061B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.060B 0.00
Vaccinex (VCNX) United States $0.057B 0.00
Pulmatrix (PULM) United States $0.057B 0.00
Appili Therapeutics (APLIF) Canada $0.055B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.055B 0.00
Soligenix (SNGX) United States $0.054B 0.00
BioCardia (BCDA) United States $0.053B 0.00
Cleveland BioLabs (CBLI) United States $0.053B 0.00
Yumanity Therapeutics (YMTX) United States $0.052B 0.00
Celsion (CLSN) United States $0.051B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Advaxis (ADXS) United States $0.049B 0.00
Chanticleer Holdings (SONN) United States $0.047B 0.00
AEterna Zentaris (AEZS) United States $0.044B 0.00
Spherix (AIKI) United States $0.043B 0.00
Prana Biotechnology (ATHE) Australia $0.043B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Alimera Sciences (ALIM) United States $0.041B 0.00
ATyr Pharma (LIFE) United States $0.041B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.036B 0.00
Neuralstem (SNCA) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.021B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
CTD Holdings (CYTH) United States $0.010B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Benitec Biopharma (BNTC) United States $0.005B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00